PAGE 15
HIV NUTRITION UPDATE
VOLUME 6, ISSUE 6
(Return to page 14)

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 



 
 
 
 
 
 
 
 
 
 
 

"Psyllium ingestion also reduced plasma triglyceride concentrations in men yet increased them in postmenopausal women."
Diet And HIV Infection

A number of studies published since our HIV ReSource Review issues on diet and lipodystrophy offer further information on psyllium and omega-3 fatty acids. Omega-3 fatty acids are a class of polyunsaturated fatty acids that include alpha-linolenic acid, eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). As noted in the Jan/Feb 2000 HIV ReSource Review issue, consumption of food containing omega-3 fatty acids may help to protect people against coronary artery disease (CAD). Studies also show that EPA and DHA reduce levels of triglycerides. Investigators recently examined the relationship between dietary linolenic acid and CAD in 4,584 participants in the National Heart, Lung, and Blood Institute Family Heart Study. In the cross-sectional study, investigators assessed participants' diets with a semi-quantitative food-frequency questionnaire and found that a higher intake of either linolenic or linoleic acid was inversely related to the prevalence of CAD. Another small one-month study of psyllium at 15 grams per day reduced plasma LDL-cholesterol concentrations and did not effect HDL-cholesterol levels. Psyllium ingestion also reduced plasma triglyceride concentrations in men yet increased them in postmenopausal women.

Sources

1. Djousse L, Pankow JS, Eckfeldt JH, Folsom AR, et al. Relation between dietary linolenic acid and coronary artery disease in the National Heart, Lung, and Blood Institute Family Heart Study. Am J Clin Nutr 2001;74(5):612-9.

2. Vega-Lopez S, Vidal-Quintanar RL, Fernandez ML. Sex and hormonal status influence plasma lipid responses to psyllium. Am J Clin Nutr 2001;74(4):435-41.


Bone Disorders

The incidence of avascular necrosis (AVN) is increasing in HIV-infected patients. (1) Although corticosteroid use is significantly associated with AVN, its pathogenesis is likely to be multifactorial. (2) Treatment advocate, Nairy Ghazourian notes that certain preclinical signs and symptoms signal the presence of AVN. An on-line treatment information newsletter from Seattle Treatment Education Project notes what HIV-positive people can do now to lessen the risk of AVN. The use of shark cartilage to treat this condition is questionable.

Sources
1. Boyle B. HIV-associated Risk Factors in the Development of Osteonecrosis. 10 Aug 2001.

2. Glesby MJ, Hoover DR, Vaamonde CM. Osteonecrosis in patients infected with human immunodeficiency virus: a case-control study. J Infect Dis 2001;184(4):519-23.

Caffeine appears to have a role in bone loss based on recent study results. Reports from a cross-sectional and a 3-year longitudinal study of bone mineral density (BMD) in 489 postmenopausal women found that those with high caffeine intakes had significantly higher rates of bone loss at the spine than did those with low intakes. Investigators reported that women with the tt genetic variant of VDR (as opposed to the TT genotype) had significantly higher rates of bone loss at the spine when their caffeine intake was more than 300 milligrams (18 ounces of brewed coffee per day. 

Source: Rapuri PB, Gallagher JC, Kinyamu HK, Ryschon KL. Caffeine intake increases the rate of bone loss in elderly women and interacts with vitamin D receptor genotypes. Am J Clin Nutr 2001;74(5):694-700.
 
 

(Forward to page 16)


 
 

 
 
Copyright 2002 HIV ReSources, Inc. Sharing this newsletter in any form with non-subscribers is strictly prohibited. Library/Institution subscribers are permitted to share HIV Nutrition Update html newsletter pages with up to five (5) employees or volunteers. NO other redistribution allowed. 
 
Please Help To Keep This Page Updated By Notifying
The Webmaster If You Find A Link That's Outdated!
 
HIV ReSources, Inc.
PO Box 39385
Fort Lauderdale, FL
33339-9385
USA
 
© 1998-2002  HIV ReSources, Inc.
Any use of the information presented herein is done strictly at your own risk.
No responsibility is implied or intended on the part of HIV ReSources Inc,
the editor, or the publisher. Information on this site should not
be construed as an endorsement of any kind.
 
5/10/2002